2Chiou SH, Wu WT, Huang YY, et al. Effects of the characteristics of chitosan on controlling drug release of chitosan coated PLLA microspheres [J]. J Microencapsul, 2001, 18 (5):613-625.
3Shimono N, Takatori T, Uecla M, et al. Multiparticulate chitosan-dispersed system for drug delivery [J]. Chem. Pharm Bull (Tokyo), 2003, 51 (6): 620-624.
4Xu Y, Du Y, Huang R, et al. Preparation and modification of N- (2-hydroxyl) propyl-3-trimethyl ammonium chitosan chloride nanoparticle as a protein carrier [J]. Biomaterials, 2003,24 (27): 5015-5022.
5EI-Gibaly I. Development and in vitro evaluation of novel floating chitosan microcapsules for oral use:comparison with non-floating chitosan microspheres [J]. Int J Pharm, 2002,249(1-2): 7-21.
6Jaaskelainen I, Peltola S, Honkakoski P, et al. A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides [J]. EurJPharm Sci, 2000,10(3): 187-193.
7Li XW, Lee DK, Chan AS, et al. Sustained expression in mammalian cells with DNA complexed with chitosan nanoparticles [J]. Biochim Biophys Acta, 2003, 1630 (1): 7-18.
8Lorenzo-Lamosa ML, Remunan-Lopez C, Vila-Jato JL, et al.Design of microencapsulated chitosan microspheres for colonic drug delivery [J]. J Controlled Release, 1998, 52 (1-2): 109-118.
9DesNoyer JR, McHuqh AJ. The effect of pluronic on the protein release kinetics of an injectable drug delivery system [J]. J Controlled Release, 2003, 86 (1): 15-24.
10Shishido SM, Seabra AB, Loh W, et al. Thermal and photochemical nitric oxide release from S-nitrosothiols incorporated in pluronic F127 gel: potential uses for local and controlled nitric oxide release [J]. Biomaterials, 2003, 24 (20): 3543-3553.
